Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Registry Study to Determine Utilisation Patterns in Patients Receiving Angiox®, and Collect Descriptive Safety and Outcome Data to Inform the Risk Management Strategy for Europe.

NCT01011504 is registered in ClinicalTrials.gov with The Medicines Company as lead sponsor.

NCT NCT01011504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01011504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Registry Study to Determine Utilisation Patterns in Patients Receiving Angiox®, and Collect Descriptive Safety and Outcome Data to Inform the Risk Management Strategy for Europe.
Lead sponsor
The Medicines Company
Phase
Observational
Overall status
Completed
Start date
May 31, 2009
Completion date
December 31, 2010
Enrollment
2,019 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

nste-acs (nstemi and ua), stable angina (sa), stemi (ste-acs)